Stockreport

Novo Nordisk faces a defining year in the obesity drug market. It's off to a dramatic start [CNBC]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF This month, Novo sued telehealth provider Hims & Hers for alleged patent infringement and issued a 2026 outlook that disappointed investors, all while its stock swung w [Read more]